market access

Market Access

The stealth market access strategy that’s quietly making man...

There is an under-the-radar market access strategy that some manufacturers have implemented, but many others remain unaware of.

Market Access

Partner Content

The Inaugural Market Access for CNS Therapeutics Summit Has ...

The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...

Market Access

Looking ahead in 2025 and MHRA reliance

International reliance is a mechanism whereby certain medical devices could access the UK market more quickly if they have already been approved by a comparable regulator, rather than under

Market Access

12 Questions with Patrick Oliver

Patrick Oliver, General Manager of Alfasigma UK and Ireland, brings 36 years of industry expertise to the role.

Market Access

Part Two: Navigating the complexities of global market acces...

The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world.

Market Access

Part One: Overcoming challenges and seizing opportunities in...

The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked condi

The stealth market access strategy that’s quietly making man...

The Inaugural Market Access for CNS Therapeutics Summit Has ...

Looking ahead in 2025 and MHRA reliance

12 Questions with Patrick Oliver

Part Two: Navigating the complexities of global market acces...

Part One: Overcoming challenges and seizing opportunities in...

NHS staff 'feel unprepared for digital transformation'

How to meet your physicians where they are online

market access

Editor's Picks